The Study of Metastatic Pancreatic Adenocarcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Metastatic Pancreatic Adenocarcinoma
Interventions
DRUG

S-1,Leucovorin,Oxaliplatin,Gemcitabine

Biweekly S-1, Leucovorin, Oxaliplatin and Gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

National Taiwan University Hospital

OTHER

collaborator

National Cheng-Kung University Hospital

OTHER

collaborator

Chang Gung Memorial Hospital

OTHER

lead

National Health Research Institutes, Taiwan

OTHER

NCT01415713 - The Study of Metastatic Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter